515 related articles for article (PubMed ID: 27916678)
21. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
[TBL] [Abstract][Full Text] [Related]
22. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
[TBL] [Abstract][Full Text] [Related]
23. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
24. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
25. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
26. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
[TBL] [Abstract][Full Text] [Related]
28. The fate of low grade dysplasia in ulcerative colitis.
Ullman TA; Loftus EV; Kakar S; Burgart LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 2002 Apr; 97(4):922-7. PubMed ID: 12008669
[TBL] [Abstract][Full Text] [Related]
29. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
Thomas T; Abrams KA; Robinson RJ; Mayberry JF
Aliment Pharmacol Ther; 2007 Mar; 25(6):657-68. PubMed ID: 17311598
[TBL] [Abstract][Full Text] [Related]
31. Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Derikx LAAP; Nissen LHC; Smits LJT; Shen B; Hoentjen F
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):798-806.e20. PubMed ID: 26407752
[TBL] [Abstract][Full Text] [Related]
32. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?
Murphy J; Kalkbrenner KA; Blas JV; Pemberton JH; Landmann RG; Young-Fadok TM; Etzioni DA
Colorectal Dis; 2016 Jul; 18(7):703-9. PubMed ID: 26921877
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
34. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
[TBL] [Abstract][Full Text] [Related]
35. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
Thomas T; Nair P; Dronfield MW; Mayberry JF
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
[TBL] [Abstract][Full Text] [Related]
36. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
37. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
[TBL] [Abstract][Full Text] [Related]
38. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis.
Leidenius MH; Färkkilä MA; Kärkkäinen P; Taskinen EI; Kellokumpu IH; Höckerstedt KA
Scand J Gastroenterol; 1997 Jul; 32(7):706-11. PubMed ID: 9246712
[TBL] [Abstract][Full Text] [Related]
39. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.
Jess T; Rungoe C; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):639-45. PubMed ID: 22289873
[TBL] [Abstract][Full Text] [Related]
40. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
